-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Amrize, Lowers Price Target to $65

Benzinga·04/15/2026 15:48:45
Listen to the news
Wells Fargo analyst Timna Tanners maintains Amrize (NYSE:AMRZ) with a Overweight and lowers the price target from $66 to $65.